Crossmark

Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity

Crossref DOI link: https://doi.org/10.1073/pnas.1521825113

Published Online: 2016-05-09

Published Print: 2016-05-24

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Gupta, Achla

Gomes, Ivone

Bobeck, Erin N.

Fakira, Amanda K.

Massaro, Nicholas P.

Sharma, Indrajeet

Cavé, Adrien

Hamm, Heidi E.

Parello, Joseph

Devi, Lakshmi A. https://orcid.org/0000-0002-2179-2874
Funding

Funding for this research was provided by:

HHS | National Institutes of Health (DA008863)

HHS | National Institutes of Health (NS026880)

HHS | National Institutes of Health (T32 DA007135)
License Information

Version of Record valid from 2016-11-09
More Information

Publication History

Published: 2016-05-09